Related Experiment Video
Updated: Jan 28, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
A Theoretical Model for Predicting and Optimizing In Vitro Screening of Potential Targeted Alpha-Particle Therapy
Wenzong Ma1, Xudong Wang1, Weihao Liu2
1a State Key Laboratory of Nuclear Physics and Technology, School of Physics, Peking University, Beijing 100871, P. R. China.
Abstract:
One highly promising approach to cancer treatment, especially for tumors that have undergone micrometastasis, is targeted alpha-particle therapy (TAT). However, the development of a TAT drug has been impeded due to numerous unsuccessful attempts to establish effective in vitro screening methods. The goal of this study was to construct a model to predict and optimize in vitro screening of potential TAT drugs. Based on mean field hypothesis, microdosimetry and the classic linear-quadratic equation, a novel model was built, which can predict our own in vitro experiments and replicate published data from others. Interestingly, this model can also be used to quickly optimize several key parameters in in vitro screening of potential TAT drugs, instructing the optimal combinations of the expression level of antigen, the binding affinity of antibody and drug antibody ratio, as well as others. In addition, to conveniently evaluate the therapeutic benefit of different drugs, a simple but universal parameter, the death ratio, is proposed. To our knowledge, this is the first model that can predict and guide the optimization of in vitro potential targeted alpha-particle therapy drug screening, which may then accelerate the development of potential targeted alpha-particle therapy drugs dramatically.
Insights
A new model predicts and optimizes in vitro screening for targeted alpha-particle therapy (TAT) drugs. This approach accelerates the development of novel cancer treatments by guiding drug selection and improving screening efficiency.
Area of Science:
- Oncology
- Radiotherapy
- Biophysics
Background:
- Targeted alpha-particle therapy (TAT) shows promise for treating micrometastatic cancers.
- Developing effective in vitro screening methods for TAT drugs has been a significant challenge.
Purpose of the Study:
- To develop a predictive model for optimizing in vitro screening of potential TAT drugs.
- To guide the selection and development of more effective TAT agents.
Main Methods:
- A novel model was constructed based on mean field hypothesis, microdosimetry, and the linear-quadratic equation.
- The model was validated against the study's own in vitro experiments and published data.
- Key parameters for in vitro screening optimization were identified.
Main Results:
- The model accurately predicts in vitro experimental outcomes and replicates existing data.
- The model optimizes crucial parameters like antigen expression, antibody binding affinity, and drug-antibody ratio.
- A universal parameter, the 'death ratio,' was proposed for evaluating therapeutic benefit.
Conclusions:
- This is the first model capable of predicting and optimizing in vitro screening for TAT drugs.
- The model has the potential to significantly accelerate the development of new TAT cancer therapies.
- The proposed 'death ratio' offers a standardized method for assessing drug efficacy.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
07:25Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
Related Concept Videos
Drug Therapy
Antianxiety Medications
Targeted Cancer Therapies
There are several types of targeted therapies against...
Subatomic Particles
In Vitro Drug Dissolution: Compendial Testing Models I
In Vitro Drug Dissolution: Compendial Testing Models II
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...